Recent Company News

• 04:18 PM ET Mar 11, 2026
  

  Transcript Intelligence: Oxford Nanopore Technologies at Barclays Global Healthcare Conference

• 07:54 AM ET Mar 02, 2026
  

  Transcript Intelligence: Oxford Nanopore Technologies Q4 Earnings Guidance

• 07:53 AM ET Mar 02, 2026
  

  Transcript Intelligence: Oxford Nanopore Technologies Q4 Earnings Q&A

• 02:13 AM ET Mar 02, 2026
  

  Oxford Nanopore Technologies reports FY net income (£145.2M) vs FactSet (£139.0M) [10 est, (£149.9)-(129.5M)]; guides FY26 revenue growth of ~21-25% (133.0000p, 0)

• 10:03 AM ET Feb 27, 2026
  

  Oxford Nanopore Technologies notes that in the Australian patent proceedings against MGI Australia Pty Ltd. et al., MGI has conceded that its "Cyclone SEQ WT02" infringes four of Oxford Nanopore's Australian patents (133.0000p, -1)

• 06:05 PM ET Jan 12, 2026
  

  Transcript Intelligence: Oxford Nanopore Technologies at J.P. Morgan Healthcare Conference (154.0000p, 0)

• 05:01 PM ET Jan 12, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 02:51 AM ET Jan 12, 2026
  

  StreetAccount Summary - European pre-market trading update

• 02:04 AM ET Jan 12, 2026
  

  Oxford Nanopore Technologies expects FY revenue £223M-224M vs FactSet £219.2M [7 est, £213.7-222.6M] (141.0000p, 0)

• 01:36 AM ET Jan 12, 2026
  

  Oxford Nanopore Technologies achieves first IVD registration in UK and Europe for GridION Dx (141.0000p, 0)